Back

Prognosis of biodegradable polymer drug-eluting stents versus second-generation durable polymer drug-eluting stents in acute myocardial infarction patients following percutaneous coronary intervention

26 August 2018 (12:00 - 12:15)
Organised by:
Congress Presentation Part of: Outcome of coronary stenting up to 10 years Stents ESC Premium Access ESC Congress 2018

About the speaker

Photo
Assistant Professor Jeong Cheon Choe

Pusan National University Hospital, Pusan (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Differential effectiveness of drug-coated balloon vs. drug-eluting stent for bare-metal or drug-eluting stent restenosis: a primary prespecified subanalysis from the DAEDALUS study.
Doctor D. Giacoppo (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Up to 10-year outcome after simple crossover stenting in left main without strut opening over ostial circumflex artery
Doctor Y. Cho (Daegu, KR)
Abstract
Presentation thumbnail
Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study.
Doctor M. Tajstra (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness analysis of increased use of percutaneous coronary intervention in acute coronary syndrome patients from 6 European countries.
Doctor I. Roman Degano (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Outcome of coronary stenting up to 10 years

The Event

Event poster

ESC Congress 2018

26 August 2018 12:00 CET
You may be interested in
thumbnail
Congress Session
Complex PCI in practice: tips and tricks to take home
thumbnail
Congress Presentation
'My bleeding heart': tamponade – detection and management
thumbnail
Congress Session
PCI complications: the lyrics from my worst nightmares

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources